Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
Clinical trial NCT06843317 · RECRUITING
Trial details
- NCT number
- NCT06843317
- Sponsor
- Clover Biopharmaceuticals USA, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-21
- Primary completion
- 2026-03-03
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.